Immunogenic versus tolerogenic phagocytosis during anticancer therapy …

Immunogenic versus tolerogenic phagocytosis during anticancer therapy …

The mechanisms of cancer cell death elicited by anticancer therapy and the type of phagocytes (e.g., tumour-resident versus therapy-recruited) involved in their clearance, are decisive factors between inducing anti-inflammatory responses or TAA

(Visited 1 times, 1 visits today)
6
Like
Save

Comments

Comments are disabled for this post.